HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Forecast & Target Price

View the latest analyst price targets and forecasts to stay informed on market expectations. Click here to open.

LLY

Lilly(Eli) & Co

Last Close
Dec 03 • 01:23PM ET
812.66
Dollar change
+12.86
Percentage change
1.61 		%
Healthcare • Drug Manufacturers - General • USA • NYSE
Peers: PFE MRK JNJ BMY GILD AMGN ABBV REGN BIIB VRTX
 | Held by: VTI VOO SPY IVV VUG XLV IWF VHT QUAL IVW
Scroll to Statements
IndexS&P 500 P/E88.90 EPS (ttm)9.14 Insider Own10.39% Shs Outstand950.22M Perf Week7.64%
Market Cap771.48B Forward P/E36.25 EPS next Y22.42 Insider Trans-1.52% Shs Float850.67M Perf Month-0.77%
Income8.37B PEG2.69 EPS next Q5.47 Inst Own72.75% Short Float0.77% Perf Quarter-14.12%
Sales40.86B P/S18.88 EPS this Y109.91% Inst Trans5.53% Short Ratio1.83 Perf Half Y-2.39%
Book/sh14.99 P/B54.23 EPS next Y68.99% ROA12.54% Short Interest6.54M Perf Year39.15%
Cash/sh3.71 P/C219.27 EPS next 5Y33.00% ROE65.75% 52W Range561.65 - 972.53 Perf YTD39.41%
Dividend Est.5.45 (0.67%) P/FCF551.13 EPS past 5Y13.74% ROI19.34% 52W High-16.44% Beta0.40
Dividend TTM5.20 (0.64%) Quick Ratio0.97 Sales past 5Y9.91% Gross Margin80.91% 52W Low44.69% ATR (14)23.24
Dividend Ex-DateNov 15, 2024 Current Ratio1.27 EPS Y/Y TTM68.88% Oper. Margin35.33% RSI (14)52.33 Volatility2.17% 2.89%
Employees43000 Debt/Eq2.19 Sales Y/Y TTM27.41% Profit Margin20.48% Recom1.57 Target Price1011.81
Option/ShortYes / Yes LT Debt/Eq2.04 EPS Q/Q1780.56% Payout77.91% Rel Volume0.60 Prev Close799.80
Sales Surprise-5.44% EPS Surprise-16.97% Sales Q/Q20.43% EarningsOct 30 BMO Avg Volume3.58M Price812.66
SMA203.82% SMA50-4.39% SMA200-2.90% Trades Volume1,328,034 Change1.61%
Date Action Analyst Rating Change Price Target Change
Nov-15-24Initiated Wolfe Research Outperform $1000
Oct-17-24Initiated Bernstein Outperform $1100
Sep-13-24Resumed Citigroup Buy $1060
Aug-12-24Upgrade Deutsche Bank Hold → Buy $1025
Feb-21-24Downgrade DZ Bank Buy → Hold $820
Feb-16-24Reiterated Morgan Stanley Overweight $805 → $950
Dec-21-23Downgrade Daiwa Securities Buy → Outperform $660 → $610
Nov-09-23Initiated Deutsche Bank Hold $535
Oct-20-23Resumed UBS Buy $612 → $710
Aug-09-23Upgrade Jefferies Hold → Buy $408 → $615
Show Previous Ratings
Dec-02-24 01:22PM
Four oral GLP-1R products in Phase III trials as race intensifies
(Clinical Trials Arena)
12:19PM
Diabetes advocacy group discourages use of compounded GLP-1 drugs
(BioPharma Dive)
11:22AM
Why Is Eli Lilly and Company (LLY) Among Ken Fishers Top Stock Picks Heading Into 2025?
(Insider Monkey)
07:45AM
Analyst Report: Eli Lilly and Company
(Morningstar Research)
Dec-01-24 04:27PM
Why Is Eli Lilly and Company (LLY) Among Louis Navelliers Top Stock Picks Heading Into 2025?
(Insider Monkey)
07:00AM Loading…
Nov-30-24 07:00AM
Eli Lilly and Novo Nordisks Obesity Moat Just Got Stronger
(The Wall Street Journal)
Nov-29-24 04:28PM
The Score: GM, Macys, Novo Nordisk and More Stocks That Defined the Week
(The Wall Street Journal)
11:36AM
Galderma Bets on Skin Drug to Turn Around Pharma Business
(The Wall Street Journal)
11:31AM
Why Is Lilly (LLY) Down 5% Since Last Earnings Report?
(Zacks)
09:00AM
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
(Zacks)
06:30AM
Radiopharmaceutical trials face extra complexities due to nuclear red tape
(Clinical Trials Arena)
Nov-28-24 07:30AM
Down More Than 20% From Its High, Is Now the Time to Buy Eli Lilly Stock?
(Motley Fool)
Nov-27-24 02:37PM
Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney
(CNBC TV)
12:44PM
MHRA approves Eli Lillys Alzheimers diagnostic imaging agent Tauvid
(Medical Device Network)
12:17PM
The race for approval: oral GLP-1R therapies in obesity
(Pharmaceutical Technology)
04:35AM Loading…
04:35AM
The Ultimate Pharmaceutical Stock to Buy With $1,000 Right Now
(Motley Fool)
03:57AM
Why Amgen's Weight Loss Result Is a Win for Eli Lilly
(Motley Fool)
Nov-26-24 05:16PM
Amgen Dives 5% Despite 'Truly Remarkable' Results For Obesity Treatment
(Investor's Business Daily)
04:51PM
S&P 500 Gains and Losses Today: NRG Energy Stock Surges After Analyst Upgrade
(Investopedia)
03:41PM
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
(The Wall Street Journal)
02:23PM
Eli Lilly Pops After Biden Proposes Medicare Cover Obesity Drugs. Is Lilly Stock A Buy?
(Investor's Business Daily)
02:18PM
Novo Nordisk Says White House Obesity Plan Is Step in Right Direction
(The Wall Street Journal)
02:11PM
Eli Lilly Stock Climbs 5% as White House Backs Medicare Obesity Drug Proposal
(GuruFocus.com)
01:49PM
Medicare Could Pay for Wegovy. Dont Count On It.
(Barrons.com)
01:28PM
Amgen Stock Sinks as Obesity Drug Test Results Fail To Meet Expectations
(Investopedia)
01:26PM
Amgen Stock Dives After Weight-Loss Drug Data. Heres What to Know.
(Barrons.com)
01:04PM
Amgen Crashes 9% Despite 'Truly Remarkable' Results For Obesity Treatment
(Investor's Business Daily)
12:44PM
Eli Lilly, Novo Nordisk Stocks Gain as Biden Moves to Expand Coverage of Weight-Loss Drugs
(Investopedia)
12:33PM
Biden Proposal to Cover Obesity Drugs Sets Up Quandary for Trump
(Bloomberg)
12:03PM
Top Stock Movers Now: Amgen, Best Buy, JM Smucker, and More
(Investopedia)
11:31AM Loading…
11:31AM
Amgen Falls as Weight-Loss Shot Results Disappoint Street
(Bloomberg)
10:17AM
Amgen Obesity Drug Cut Weight In Closely Watched Study
(The Wall Street Journal)
09:54AM
Amgen Crashes After Weight-Loss Drug Only Meets Eli Lilly's Zepbound
(Investor's Business Daily)
09:16AM
Amgen shows 20% weight loss in once-monthly injectable MariTide
(Yahoo Finance)
08:54AM
Amgen Crashes 12% After Weight-Loss Drug Meets Eli Lilly's In A Key Test
(Investor's Business Daily)
08:32AM
Amgen Stock Dives Despite Positive Weight-Loss Drug Data. What to Know.
(Barrons.com)
Nov-25-24 04:16PM
Hims & Hers Shares Jump as Trump FDA Pick Seen as Major Ally
(Bloomberg)
02:51PM
Allurion launches compounded GLP-1 program as FDA aims to ends access
(Yahoo Finance)
02:51PM
Allurion launches compounded GLP-1 program as FDA aims to end access
(Yahoo Finance)
02:38PM
Trumps Made His Health Picks. What They Mean for the Sector.
(Barrons.com)
04:21AM
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
(Motley Fool)
Nov-24-24 02:22PM
Eli Lilly's (LLY) Breakthroughs: Hedge Funds' New Healthcare Favorite
(Insider Monkey)
Nov-23-24 10:00AM
Billionaire Israel Englander Increased His Stake In Eli Lilly During the Third Quarter: Should You?
(Motley Fool)
08:27AM
Jim Cramer on Eli Lilly and Company (LLY): Its Valuable
(Insider Monkey)
06:15AM
2 Incredible Growth Stocks to Buy With $1,000 Right Now
(Motley Fool)
Nov-22-24 05:20PM
Sanofi Plans to Change Hospital Drug-Discount Program
(The Wall Street Journal)
04:17PM
RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
(Investor's Business Daily)
01:32PM
Moderna Stock Jumps Following Bullish Sales View at Healthcare Conference
(Investopedia)
11:00AM
Is Eli Lilly Stock A Sell After Kennedy-Tied Woes Rankled Shares?
(Investor's Business Daily)
09:34AM
The FDA Cant Decide Whether Zepbound Is in Shortage. Its Good News for Hims & Hers Stock.
(Barrons.com)
09:15AM
Investing in Pharma Stocks? Check These 3 Things First
(Motley Fool)
08:00AM
Weight-Loss Drugs Don't Seem To Impress RFK Jr. Should Eli Lilly, Novo Nordisk Investors Worry?
(Investor's Business Daily)
05:45AM
Goldman Sachs: Eli Lilly and Company (LLY) Is A Top Growth Investor Stock
(Insider Monkey)
Nov-21-24 10:00AM
Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
(Motley Fool)
05:15AM
Eli Lilly, Verge announce milestones in ALS collaboration
(TipRanks)
04:35AM
Versant startup sets out to make a new type of obesity drug
(BioPharma Dive)
02:00AM
Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
(Barrons.com)
Nov-20-24 06:04PM
Jim Cramer on Eli Lilly and Company (LLY): Im Kind Of Blown Away
(Insider Monkey)
11:14AM
Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
(Quartz)
10:10AM
China-based biotech Laekna teams up with Lilly to develop muscle preserving obesity drug
(Reuters)
08:24AM
Eli Lilly Option Trade Produces $1,125, If You Can Tolerate The Heavy Risk
(Investor's Business Daily)
05:48AM
Is It Time to Sell Eli Lilly and Pfizer Stocks?
(Motley Fool)
05:00AM
Verge Genomics Announces Milestones in Collaboration with Lilly to Discover and Develop Novel Treatments for ALS
(GlobeNewswire)
03:30AM
RFK Jr. Sparks New Worries About Obesity Drugs. Heres What Investors Should Focus on Instead.
(Barrons.com)
Nov-19-24 04:30PM
Lilly announces changes on board of directors
(PR Newswire)
01:08PM
Eli Lilly's Investigational Drug Cuts Sticky Cholesterol Levels By Almost 86%
(Benzinga)
09:41AM
Heres Why Eli Lilly and Company (LLY) is on Detractors List of Madison Sustainable Equity Fund
(Insider Monkey)
05:30AM
Makers of Weight-Loss Drugs Want Your Employer to Pay for Them
(The Wall Street Journal)
05:30AM
Employers Get Pressure to Pay for Drugs Like Wegovy
(The Wall Street Journal)
Nov-18-24 05:49PM
RFK Jr.'s HHS nomination sparks concern over pharma stocks
(Yahoo Finance Video)
02:52PM
Lilly's muvalaplin lowered lipoprotein(a) levels in adults with high risk for cardiovascular events by up to 85% at highest tested dose
(PR Newswire)
01:27PM
How Robert F. Kennedy Jr. could impact the healthcare sector as secretary of health
(Yahoo Finance)
10:04AM
Eli Lilly's Zepbound/Mounjaro Shows Cardiovascular Benefits In Patients With Obesity-Related Heart Failure
(Benzinga)
09:00AM
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
(Zacks)
06:03AM
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
(Motley Fool)
06:02AM
Exclusive: Medicaid fuels US coverage of Novo, Lilly weight-loss drugs
(Reuters)
05:28AM
Eli Lilly follows J&J in suing Biden administration over 340B rebates
(Healthcare Dive)
03:53AM
Eli Lilly reports outcomes from Phase III trial of tirzepatide for HFpEF
(Clinical Trials Arena)
12:42AM
Analyst Report: Eli Lilly and Company
(Morningstar Research)
Nov-17-24 08:32AM
If You Bought 1 Share of Eli Lilly in 1984, Here's How Many Shares You Would Own Now
(Motley Fool)
07:00AM
Eli Lilly and Novo Want to Shake off Ozempic Copycats. Are They Ready to Meet Demand?
(The Wall Street Journal)
06:42AM
Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now
(Motley Fool)
Nov-16-24 10:00AM
Lilly's tirzepatide reduced the risk of worsening heart failure events by 38% in adults with heart failure with preserved ejection fraction (HFpEF) and obesity
(PR Newswire)
09:00AM
The weight-loss frenzy is making some pharma stocks much more volatile. Will the drama continue?
(Yahoo Finance)
Nov-15-24 05:24PM
Lilly Sues U.S. to Change Hospital Drug Discount Payments
(The Wall Street Journal) -5.09%
04:06PM
Three-Stock Lunch: Eli Lilly, Transdigm,
(CNBC TV)
12:04PM
Vaccine Maker Stocks Slump After RFK Jr. Nominated as HHS Head
(Investopedia)
09:34AM
Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
(The Wall Street Journal)
09:02AM
Eli Lilly, J&J Sue US Over Rejected Changes To Drug Discounting Program
(Investopedia)
06:45AM
RFK Jr. News Hits Global Pharma Stocks
(The Wall Street Journal)
04:05AM
Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?
(Motley Fool)
12:05AM
Lilly sues US agency over block on its drug-rebate program
(Reuters)
Nov-14-24 01:53PM
5 Healthcare Stocks to Buy in a Beaten-Up Sector
(Barrons.com)
07:15AM
Is AstraZeneca a Buy as It Eyes the Weight Loss Market?
(Motley Fool)
07:00AM
2 Top Growth Stocks to Buy on the Dip
(Motley Fool)
06:19AM
3 Ultra-Safe Dividend Stocks That Have Been Paying Dividends for More Than 100 Years
(Motley Fool)
05:29AM
Lilly reports trial results of tirzepatide for treating obesity and pre-diabetes
(Clinical Trials Arena)
12:24AM
Eli Lilly's Tirzepatide Reduces Type 2 Diabetes Risk by 94% in Long-Term Study
(GuruFocus.com)
Nov-13-24 05:05PM
Treatment with tirzepatide in adults with pre-diabetes and obesity or overweight resulted in sustained weight loss and nearly 99% remained diabetes-free at 176 weeks
(PR Newswire)
04:06PM
Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand?
(Investor's Business Daily)
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Zakrowski Donald AOfficerNov 08 '24Proposed Sale803.38900723,042Nov 08 04:54 PM
Zakrowski Donald ASVP, Finance, & CAONov 08 '24Sale803.38900723,0425,480Nov 08 04:18 PM
Montarce LucasEVP & CFONov 01 '24Option Exercise0.001,074011,541Nov 05 04:15 PM
Hernandez EdgardoEVP & Pres., Mfg. OperationsNov 01 '24Option Exercise0.001,687031,369Nov 05 04:14 PM
Dozier EricEVP, HR & DiversityNov 01 '24Option Exercise0.001,53408,724Nov 05 04:13 PM
LILLY ENDOWMENT INC10% OwnerSep 03 '24Sale966.6924,08423,281,84096,891,978Sep 04 04:05 PM
LILLY ENDOWMENT INC10% OwnerAug 27 '24Sale968.4624,55223,777,66896,916,062Aug 28 04:05 PM
Zakrowski Donald AOfficerAug 26 '24Proposed Sale950.00750712,500Aug 26 04:47 PM
Zakrowski Donald ASVP, Finance, & CAOAug 26 '24Sale950.00750712,5006,380Aug 26 04:21 PM
LILLY ENDOWMENT INC10% OwnerAug 22 '24Sale966.333,1963,088,38296,940,614Aug 23 04:05 PM
LILLY ENDOWMENT INC10% OwnerAug 22 '24Proposed Sale951.97215,000204,673,550Aug 22 12:54 PM
LILLY ENDOWMENT INC10% OwnerJul 10 '24Sale939.82210,000197,361,39896,943,810Jul 11 04:00 PM
LILLY ENDOWMENT INC10% OwnerJul 08 '24Sale918.6493,59385,977,95497,153,810Jul 09 04:00 PM
LILLY ENDOWMENT INC10% OwnerJul 05 '24Sale915.1852,36947,927,19497,247,403Jul 08 04:00 PM
LILLY ENDOWMENT INC10% OwnerJul 03 '24Sale915.318,8488,098,65597,299,772Jul 03 04:00 PM
LILLY ENDOWMENT INC10% OwnerJul 01 '24Sale915.2658,74953,770,77697,308,620Jul 02 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 28 '24Sale915.021,4411,318,54597,367,369Jul 01 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 25 '24Sale903.82188,100170,009,26297,368,810Jun 26 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 24 '24Sale902.3817,22915,547,06897,556,910Jun 25 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 20 '24Sale902.679,6718,729,73397,574,139Jun 21 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 17 '24Sale885.91194,978172,733,70897,583,810Jun 18 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 14 '24Sale882.4715,02213,256,49097,778,788Jun 17 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 10 '24Sale860.7875,51064,997,27497,793,810Jun 11 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 07 '24Sale852.29139,490118,886,58797,869,320Jun 10 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 06 '24Sale837.82179,617150,485,87898,008,810Jun 07 04:00 PM
LILLY ENDOWMENT INC10% OwnerJun 05 '24Sale836.3220,38317,046,67398,188,427Jun 06 04:00 PM
Rau DiogoEVP & CIDOJun 01 '24Option Exercise0.006,300014,146Jun 04 04:14 PM
LILLY ENDOWMENT INC10% OwnerJun 03 '24Sale829.77192,794159,974,05098,208,810Jun 04 04:00 PM
Zakrowski Donald ASVP, Finance, & CAOJun 03 '24Sale819.47750614,6027,130Jun 03 04:15 PM
Norton JohnaEVP, Global QualityJun 03 '24Sale819.387,0565,781,54525,428Jun 03 04:14 PM
LILLY ENDOWMENT INC10% OwnerMay 31 '24Sale822.1122,20618,255,87198,401,604Jun 03 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 29 '24Sale811.04130,385105,747,97598,423,810May 30 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 28 '24Sale809.002,0521,660,06898,554,195May 29 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 24 '24Sale809.2192,56374,902,99898,556,247May 28 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 23 '24Sale809.9950,76741,120,96398,648,810May 24 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 22 '24Sale804.1812,97410,433,48398,699,577May 23 04:00 PM
LILLY ENDOWMENT INC10% OwnerMay 21 '24Sale805.45186,259150,021,69498,712,551May 22 04:00 PM
Zakrowski Donald ASVP, Finance, & CAOMar 11 '24Sale753.60750565,2007,880Mar 11 04:27 PM
LILLY ENDOWMENT INC10% OwnerFeb 16 '24Sale780.99169,684132,521,93098,898,810Feb 20 04:05 PM
LILLY ENDOWMENT INC10% OwnerFeb 15 '24Sale760.4650,31638,263,41799,068,494Feb 16 04:05 PM
LILLY ENDOWMENT INC10% OwnerFeb 09 '24Sale740.60206,257152,753,42899,118,810Feb 12 04:05 PM
LILLY ENDOWMENT INC10% OwnerFeb 08 '24Sale740.068,7436,470,33699,325,067Feb 09 04:05 PM
Hakim AnatEVP, GC & SecretaryFeb 01 '24Option Exercise0.004,442026,631Feb 02 04:32 PM
Yuffa IlyaEVP & President, LLY Int'lFeb 01 '24Option Exercise0.003,702016,676Feb 02 04:29 PM
Ricks David APresident, Chair, and CEOFeb 01 '24Option Exercise0.0029,6110455,054Feb 02 04:28 PM
Jonsson PatrikEVP&Pres, LLY Dia&Obe, LLY USAFeb 01 '24Option Exercise0.004,124041,065Feb 02 04:26 PM
Skovronsky DanielEVP, CSO & Pres. LRL & LLY ImmFeb 01 '24Option Exercise0.009,9410115,262Feb 02 04:25 PM
Norton JohnaEVP, Global QualityFeb 01 '24Option Exercise0.001,268031,382Feb 02 04:24 PM
Van Naarden JacobEVP & Pres., Loxo@LillyFeb 01 '24Option Exercise0.003,618015,463Feb 02 04:22 PM
White Anne E.EVP & Pres, Lilly NeuroscienceFeb 01 '24Option Exercise0.004,124062,050Feb 02 04:20 PM
LILLY ENDOWMENT INC10% OwnerJan 31 '24Sale648.0778,57350,920,92499,333,810Feb 01 04:00 PM
LILLY ENDOWMENT INC10% OwnerJan 30 '24Sale645.2276,21549,175,20099,412,383Jan 31 04:05 PM
LILLY ENDOWMENT INC10% OwnerJan 29 '24Sale645.0754,03234,854,42299,488,598Jan 30 04:05 PM
LILLY ENDOWMENT INC10% OwnerJan 16 '24Sale645.601,180761,80699,542,630Jan 17 04:05 PM
LILLY ENDOWMENT INC10% OwnerJan 11 '24Sale634.1312,3447,827,68699,543,810Jan 12 04:05 PM
LILLY ENDOWMENT INC10% OwnerJan 10 '24Sale630.59163,730103,246,37399,556,154Jan 11 04:05 PM
LILLY ENDOWMENT INC10% OwnerJan 09 '24Sale631.8134,53821,821,41399,719,884Jan 10 04:00 PM
LILLY ENDOWMENT INC10% OwnerJan 04 '24Sale630.2814,3889,068,44599,754,422Jan 05 02:15 PM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
affiliate • advertise • toggle light mode • contact • help • privacy • do not sell my data
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.